Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 21

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 21
---
 is 2 Overhill Road, Suite 400, Scarsdale, NY 10583.

(5)Based
on certain information made available to the Company and on the Schedule 13G/A filed jointly with the SEC on November 13, 2024,
by Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC (“Intracoastal”). Represents (i) 14,583,338 shares
of Common Stock issuable upon exercise of certain warrants that were exercisable as of the Record Date or will be exercisable within
60 days thereafter (with certain warrants subject to a 4.99% beneficial ownership blocker), and (ii) 136.19 shares of Series A
Preferred Stock, convertible into up to approximately 567,458 shares of Common Stock within 60 days of the Record Date (subject to a
4.99% beneficial ownership blocker).

Mr. Kopin and Mr. Asher are each managers of Intracoastal
and have shared voting control and investment discretion over the securities reported herein that are held by Intracoastal. As a result,
each of

Mr. Kopin and Mr. Asher may be deemed to have beneficial
ownership (as determined under Section 13(d) of the Exchange Act of the securities reported herein that are held by Intracoastal
Capital LLC. The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483 and the principal
business office of Mr. Asher is 111 W. Jackson Boulevard, Suite 2000, Chicago, Illinois 60604.

(6) Based on certain information made available to the Company.
Represents (i) 1,250,000 shares of Common Stock, (ii) 6,250,004 shares of Common Stock issuable upon exercise of certain warrants
that were exercisable as of the Record Date or will be exercisable within 60 days thereafter (subject to a 4.99% beneficial ownership
blocker), (iii) 2,916,664 shares of Common Stock issuable upon exercise of the Pre-Funded Warrants (subject to a 4.99% beneficial
ownership blocker), and (iv) 36.90 shares of Series A Preferred Stock, convertible into up to approximately 153,750 shares of
Common Stock within 60 days of the Record Date (subject to a 4.99% beneficial ownership blocker